Pre-sterilized syringe systems: Alba, Nexa, Fina syringes systems - Stevanato Group
Stevanato Group provides a wide range of washed, siliconized and pre-sterilized syringes systems, including bypass ones. Discover Alba, Nexa, Fina syringes systems.
Home - Managing Complexity, Delivering Value - Stevanato Group > Products & Capabilities - Stevanato Group > Drug containment solutions: Pharmaceutical glass containers - Stevanato Group > Pre-sterilized syringe systems: Alba, Nexa, Fina syringes systems - Stevanato Group
page-wrapper

Pre-sterilized and bulk syringe systems

Stevanato Group provides a wide range of washed, siliconized and pre-sterilized EZ-fill® syringe systems, including bypass ones. Available in a range of sizes from 0,5 ml to 5 mL with staked needle, Luer cone or Luer lock adapter. Bulk syringe systems are available with or without staked needle and provided in trays.

Broad range of added value services – regulatory expertise in combination products as well as characterization test in ISO 17025 accredited labs (aligned with GMP) in Stevanato Group’s Technology Excellence Centers.

Fina®: A customizable solution for your injectables

Fina® provides a flexible platform for designing a customized prefilled syringe solution. The line boasts a wide range of container sizes and matching components.

Fina® syringes are manufactured on fully automated production lines featuring 100% inline camera controls, inspecting all critical phases. As a result of using validated manufacturing processes, Fina® syringes have excellent mechanical performance and cosmetic appearance - fulfilling the most stringent AQL standards.

STAKED NEEDLE

LUER

Ml
Rigid N. Shield
Needle Shield
Tip Cap
OVS
ITC

0.5 ml

1.0 ml long

1.0 ml Short

1.25 ml

1.5 ml

2.25 ml

3.0 ml

5.0 ml

5.0 ml bypass

Off the shelf
To be developed
Upcoming
Benefits
13 Quality

Compliant with PH.Eur., USP and JP for applicable parts

25 Regulatory Expertise

Our Regulatory Affairs team can support customer drug applications and provide authorization of DMF submissions to US FDA and Health Canada

Preferred Market Choice
199 Chemical Molecule

Heparin

42 Syringe With Safety System

Vaccines

348_Water_diluent

Water For Injection

Nexa®: Optimized for high-value sensitive injectables

Extremely safe, compatible, and extremely resistant, Nexa® syringe is the preferred solution for high-value sensitive injectables drug products.

Nexa® syringes have been specifically designed to meet the dimensional requirements of auto-injectors and to ensure excellent mechanical resistance when compared to a standard syringe. These durable properties are derived through optimized product handling throughout the entire manufacturing process (no glass-to-glass contact and limited glass-to-metal contact). Advanced in-line inspection technologies carefully check products before release, minimizing the risk of in-line breakages during filling operations and reducing the number of filled rejects.

Drug stability is ensured by an ultra-low tungsten level and an optimized silicone-oil distribution along the barrel provides enhanced gliding performance, a key aspect when integrating a syringe into a drug delivery device.

STAKED NEEDLE

LUER

Ml
Rigid N. Shield
Needle Shield
Tip Cap
OVS
ITC*

1.0 ml long

1.0 ml

2.25 ml

Off the shelf

To be developed

Upcoming

 

* Additional formats of 1.25ml and 1.5ml are available upon request.

Benefits
271 Syringe Lowtungsten

Ultra-low tungsten

27 Superior Gliding Performance

Optimized break-loose and glide performance

19 Auto Injector

Easily integrates with drug delivery systems

Preferred market choice:
199A Biologic Molecule

Biologics

235 Diabetes

GLP-1

Nexa® ITC 

Nexa® is also available with Integrated Tip Cap (ITC) to streamline vaccine manufacturing processes and address evolving industry needs.

Key Factors
01

Enhanced Quality Specifications guaranteeing high performance and reliability

02

Optimized Total Cost of Ownership - Implementation of 100% inline cosmetic controls ensures consistently superior quality, reducing the likelihood of rejected units.

03

Improved Flexibility and Supply Availability - Available from 1ml to 2.25ml capacity

Alba® EZ-fill®: breakthrough solution for biologics. De-risking the development of sensitive drugs.

Alba® EZ-fill® syringes represent the best-in-class solution for biologics and ophthalmic applications addressing the key requirements of protein-based drugs, and minimizing adsorption, aggregation and inorganic extractable interaction.

STAKED NEEDLE

LUER

Ml
Rigid N. Shield
Needle Shield
Tip Cap
OVS
ITC

0.5 ml

1.0 ml long

2.25 ml

Off the shelf

To be developed

Upcoming

All Alba® EZ-fill® products have an internal coatingbased on standard silicone oil, which is cross-linked. It ensures that particle levels - caused by silicone migration during container storage - are significantly lower than ones using standard siliconization technologies. Moreover, the internal treatment offers superior gliding performance, reducing the risk of functional issues when combined with auto-injectors.

Due to the excellent properties of the layer, Alba® platform mitigates packaging-related risks and enhances drug-interaction stability.

Benefits*
92B Filled Syringe Particles

Particle reduction
Minimized subvisible particles versus conventional sprayed-on siliconized containers to alleviate potential drug-silicone interaction.

27 Superior Gliding Performance

Optimized break-loose and glide performance
Silicone lubricant layer integrity, optimized to withstand challenging formulations and aggressive conditions, helps conserve gliding performances throughout the drug shelf-life.

24 Compatibility Drug Container

Reduction risk of stalling and injection time variation
The low silicone-drug interaction helps to maintain the injection time and dose delivery with an auto-injector.

54 Filling Syringe Ok

Inorganic extractable mitigation
A barrier between the drug and the glass reduces the amount of inorganic extractables.

184 Syringe Alba

Time stability
Alba® inner coating does not undergo critical variations after contact with the placebo solution over a period of 6 months (tested @40°C/75%RH).

*Functionality, subvisible particles (MFI + Light Obscuration) and silicone layer thickness performance till 12 months stability . Internal study, 2023

Preferred market choice:
236 Monoclonal Antibodies

Protein-based therapeutics

252 Eye

Ophthalmic applications

199A Biologic Molecule

mRNA-based applications

Add-on components

As a system supplier, Stevanato Group works hand in hand with rubber manufacturers to supply best-in-class components for each intended use. The plunger rod and backstop (extended finger flange) are designed for maximum compatibility with industry rubber components and safety devices.

Add-on Specifications
43 Plunger Rod

Plunger Rods

  • 0,5 mL – 5 mL
  • PS / PP

134 Backstop

Backstops
(Extended Finger Flange)

  • 0,5 mL – 3 mL
  • PP
41 Syringe Plunger

Plungers

  • Best-in-class rubber components for all syringe formats
  • Coated / Non-coated
  • RfS / RtU

Special Thin-Wall Needle

Our Special Thin-Wall needle is a 27G and 29G ½” 5B needle with an enlarged internal channel diameter to optimize the delivery of highly viscous drug formulations without the need for bigger needles, thereby satisfying auto-injector device requirements and enhancing the overall patient experience.

Nexa® glass performance level is now available also on Nexa Flex:
Our State-of-the-Art Polymer Syringes.

Dual Chamber Syringes​

Dual chamber syringes represent the optimal choice for applications which require drugs to remain separated until just before administration. Dual chamber syringes are made up of two chambers separated by a plunger – the system allows the two substances to be reconstituted when required, preventing premature mixing of drug components while maintaining the ease of use of a pre-filled syringe system. Our syringe portfolio supports pharma companies to ensure the safe and efficient administration of complex drugs, with the ability to develop different formats, depending on the application.

White Paper & Brochure

Our new plant in Fishers (Indiana) USA

The new U.S. hub in Fishers is designed to support North American pharmaceutical customers.

Interested in High-performance syringe systems?
Submit your request